HSBC Holdings
EVLO

HSBC Holdings’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

HSBC Holdings’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-580
Closed -$145K – 3229
2020
Q4 		$145K Sell
580
-707
-55% -$87.4K ﹤0.01% 2897
2020
Q3 		$129K Hold
1,287
– – ﹤0.01% 2585
2020
Q2 		$126K Hold
1,287
– – ﹤0.01% 2482
2020
Q1 		$97K Sell
1,287
-1
-0.1% -$95 ﹤0.01% 2480
2019
Q4 		$106K Sell
1,288
-1,287
-50% -$144K ﹤0.01% 2920
2019
Q3 		$314K Buy
+2,575
New +$354K ﹤0.01% 2597

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HSBC Holdings's EVLO Position: Q1 2021 in Review

HSBC Holdings sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2021, closing a stake of 580 shares — an estimated $145K sold.

HSBC Holdings first reported a position in EVLO in Q3 2019 and held it in 6 quarters. The position peaked at $314K in Q3 2019. 62 funds tracked by Wall St. Rank hold EVLO as of Q1 2021.

  • HSBC Holdings reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • HSBC Holdings sold 580 Evelo Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $145K.
  • HSBC Holdings first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • HSBC Holdings's Evelo Biosciences, Inc. Common Stock position peaked at $314K in Q3 2019.
  • 62 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.